false
OasisLMS
Catalog
CHEST 2023 On Demand Pass
Rapid-Fire: Clinical Challenges of Patients With H ...
Rapid-Fire: Clinical Challenges of Patients With HAP and VAP
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video begins with a discussion on clinical challenges with patients who have hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). The speaker presents a case of a 73-year-old man with burns and endotracheal tube in place who develops a fever, thick secretions, and hypoxemia. A molecular test reveals the presence of three organisms: Klebsiella aerogenes, Pseudomonas aeruginosa, and Staphylococcus aureus. The audience is asked which organisms they believe and which ones they would cover. The majority of the audience believes all three organisms are present and votes accordingly. The speaker then discusses the use of molecular testing in diagnosing infections and the challenges associated with interpreting the results. The audience is asked about their experience with molecular testing, and about half of the audience indicates that they have this capability at their facilities. The speaker concludes by discussing the importance of diagnostic testing, including quantitative cultures, and the need for ongoing evaluation and reevaluation of treatment decisions based on clinical improvement and other factors such as procalcitonin levels. The audience is asked about their approach to treatment duration, with the majority indicating that they would discontinue antibiotics after a certain period of time if the patient is showing clinical improvement. The session ends with a discussion on the importance of multidisciplinary collaboration, including pharmacists, in making treatment decisions for HAP and VAP patients.
Meta Tag
Category
Chest Infections
Session ID
1130
Speaker
Kristina Crothers
Speaker
Charles Dela Cruz
Speaker
Barbara Jones
Speaker
Christian Sandrock
Track
Chest Infections
Keywords
hospital-acquired pneumonia
ventilator-associated pneumonia
clinical challenges
molecular test
Klebsiella aerogenes
Pseudomonas aeruginosa
Staphylococcus aureus
diagnosing infections
treatment decisions
multidisciplinary collaboration
×
Please select your language
1
English